Department of Microbiology, 249307National Centre of Infectious and Parasitic Diseases, Sofia, Bulgaria.
Department of Immunology, 249307National Centre of Infectious and Parasitic Diseases, Sofia, Bulgaria.
Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231163681. doi: 10.1177/03946320231163681.
Cytokine dysregulation has been proposed as one of the main culprits for severe COVID-19 and poor prognosis. We examined the parallel presence of lymphopoietic, proinflammatory, Th1, Th2, regulatory cytokines, and chemokines in the serum of 47 patients with mild, moderate, and severe COVID-19 and evaluated the association between cytokine concentrations and disease severity.
A multiplex quantitative cytokine analysis ProcartaPlex™ immunoassay was applied, using the Luminex 200X detection system (Invitrogen).
The concentrations of twelve cytokines: IL-18, IFN-gamma, TNF-alpha; IL-21; IL-1alpha, IL-1beta, IL-6, IL-22; IL-10, IL-1RA; IL-7 and IFN-alpha were consistently elevated in the studied serum samples. All examined chemokines-Eotaxin, GRO-alpha, IL-8, IP-10, MCP-1, MIP-1alpha, MIP-1beta, SDF-1alpha, and RANTES, were detectable in all studied groups, confirming their importance in mediating the adaptive immune response regardless of disease severity. The serum concentrations of six mediators: IL-1beta, IL-6, IL-18, IL-10, IL-8, and IP-10, showed statistically significant differences among the groups with different disease severity. IL-6, IL-1beta, and IL-10 were more significantly elevated in severe cases while milder symptoms were associated with lower levels of IL-8 and IP-10.
Overall, the studied chemokines demonstrated an associated production in acute COVID-19 infection. A strong correlation was observed between the Th1 mediators IL-18 and IL-10 and the proinflammatory IL-6 in the severe COVID-19 group. Our results indicated that severe COVID-19 was characterized by a dysregulated cytokine pattern whereby the Th1 immune response is outweighed by the immunoregulatory response, while inhibitory signals cannot balance the hyperinflammatory response.
细胞因子失调被认为是导致严重 COVID-19 和预后不良的主要原因之一。我们检测了 47 例轻度、中度和重度 COVID-19 患者血清中的淋巴生成、促炎、Th1、Th2、调节细胞因子和趋化因子的平行存在情况,并评估了细胞因子浓度与疾病严重程度之间的相关性。
应用多重定量细胞因子分析 ProcartaPlex™免疫分析,使用 Luminex 200X 检测系统(Invitrogen)。
在研究的血清样本中,12 种细胞因子的浓度:IL-18、IFN-γ、TNF-α;IL-21;IL-1α、IL-1β、IL-6、IL-22;IL-10、IL-1RA;IL-7 和 IFN-α持续升高。所有检测到的趋化因子-Eotaxin、GRO-α、IL-8、IP-10、MCP-1、MIP-1α、MIP-1β、SDF-1α和RANTES 在所有研究组中均可检测到,证实它们在介导适应性免疫反应方面的重要性,无论疾病严重程度如何。六种介质的血清浓度:IL-1β、IL-6、IL-18、IL-10、IL-8 和 IP-10,在不同疾病严重程度的组之间存在统计学差异。在严重病例中,IL-6、IL-1β 和 IL-10 升高更为显著,而较轻的症状与 IL-8 和 IP-10 的水平较低相关。
总的来说,研究中的趋化因子在急性 COVID-19 感染中表现出相关的产生。在严重 COVID-19 组中,观察到 Th1 介质 IL-18 和 IL-10 与促炎介质 IL-6 之间存在强烈相关性。我们的结果表明,严重 COVID-19 的特点是细胞因子模式失调,其中 Th1 免疫反应被免疫调节反应所压倒,而抑制信号不能平衡过度炎症反应。